Postoperative Chronic Cough Clinical Trial
Official title:
Effect of Disconnecting Pulmonary Vagus Nerve Branch on Chronic Cough After Unilateral Thoracoscopic Lobectomy: a Single-center, Randomized ,Single-blind, Controlled Trial
| Verified date | June 2023 |
| Source | Xuzhou Medical University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study was to determine whether disconnecting pulmonary vagus nerve branch can abatement chronic cough in patients undergoing unilateral thoracoscopic lobectomy,compared with preserving pulmonary vagus nerve branch.
| Status | Completed |
| Enrollment | 116 |
| Est. completion date | February 1, 2023 |
| Est. primary completion date | November 1, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Patients with preoperative imaging of bronchial lung cancer below the secondary bronchus ,the maximum diameter of the tumor = 5cm (T = 2) and staging check not suggesting distant and mediastinal lymph node metastasis (N = 1, M = 0) schedule to receive elective unilateral thoracoscopic lobectomy from 2019 to 2021 will be included in the trial. - ASA?-? Exclusion Criteria: - Chronic cough (>8 weeks), its causes including chronic bronchitis, asthma, gastroesophageal reflux disease, history of postnasal drip syndrome, and the use of ACEI drugs and so on; - other history of lung surgery; - patients with severe arrhythmia; - there are contraindications for anesthesia and surgery; - pregnancy and lactation. |
| Country | Name | City | State |
|---|---|---|---|
| China | Department of Anesthesiology of the Affiliated Hospital of Xuzhou Medical University | Xuzhou | Jiangsu |
| Lead Sponsor | Collaborator |
|---|---|
| Han Yuan |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The incidence of chronic cough after surgery | More than 8 weeks after surgery, there is no clear cause of cough with stable chest CT excluding the diagnosis of postnasal drip syndrome, asthma or the use of Angiotensin-converting enzyme inhibitor(ACEI), etc. | 3 months after surgery | |
| Secondary | The incidence of chronic cough after surgery | More than 8 weeks after surgery, there is no clear cause of cough with stable chest CT excluding the diagnosis of postnasal drip syndrome, asthma or the use of Angiotensin-converting enzyme inhibitor(ACEI), etc. | 1 month after surgery | |
| Secondary | The score of the LCQ-MC scale after surgery | The LCQ-MC was designed for the assessment of a chronic cough, consists of 19 items and three domains. | 1 month and 3 months after surgery | |
| Secondary | Length of operation | during the operation | ||
| Secondary | volume of bleeding | during the operation | ||
| Secondary | volume of postoperative drainage | within 30 days after surgery | ||
| Secondary | the frequence of perioperative arrhythmia | during the operation | ||
| Secondary | the incidence of Postoperative complication | pulmonary complications, intestinal obstruction, pulmonary embolism, acute respiratory failure, acute renal failure, wound infection, cerebrovascular accident | within 30 days after surgery | |
| Secondary | the score of Cough symptom | The score was used to record daily symptom score for cough severity.The scale is scored by 4 levels at day and night respectively.The higher score means worse symptom. | postoperative 1 day,2 days,3 days,4 days,5 days,6 days | |
| Secondary | the time of extubation | within 30 days after surgery | ||
| Secondary | the incidence of gastrointestinal symptoms | gastrointestinal symptoms include anorexia, belching, reflux, diarrhea, nausea | within 3 months after surgery | |
| Secondary | the incidence of postoperative hospitalization | within 30 days after surgery | ||
| Secondary | pulmonary function 30 months after surgery | maximal voluntary ventilation, diffusing capacity of the lungs for carbon monoxideand forced expiratory volume | 30 months after surgery |